ArticleFrontiers in psychiatry2026
Virtual reality based attentional bias modification training for patients with obsessive-compulsive disorder: a feasibility study.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Attentional bias modification (ABM) training is employed to modulate attentional bias and alleviate clinical symptoms in obsessive-compulsive disorder (OCD) patients. This study aimed to develop a novel, ecologically valid ABM paradigm based on virtual reality (VR). The intent was to enhance the efficacy of traditional computerized ABM and to preliminarily examine its feasibility in patients with contamination-based obsessive-compulsive disorder (OCD). Method: 15 patients with OCD who were currently receiving pharmacotherapy were recruited and allocated to either an ABM group, which received VR-ABM training twice weekly for four weeks (eight sessions in total), or a TAU group, which continued their routine outpatient treatment, including pharmacotherapy, psychotherapy, and physical therapy. Result: 5 patients in ABM group and 5 patients in TAU group completed the 4-week follow-up. VR-ABM paradigm effectively elicited target symptoms, with virtual scenarios inducing moderate levels of obsessive-compulsive symptoms and anxiety. Notably, all participants in the VR-ABM group reported the program to be appropriately challenging, effectively eliciting obsessive-compulsive symptoms and improving subjective concentration. Conclusion: These preliminary findings support the feasibility of the novel VR-ABM training in OCD and warrant further investigation in larger, controlled trials to rigorously evaluate its therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.